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ABSTRACT
Background: Microorganisms growing in a biofilm are associated with chronic and recurrent hu-
man infections and are highly resistant to antimicrobial agents. There are various methods to detect 
biofilm production like Tissue Culture Plate (TCP), Tube method (TM), Congo Red Agar meth-
od (CRA), bioluminescent assay, piezoelectric sensors, and fluorescent microscopic examination. 
Objective: This study was conducted to compare three methods for the detection of biofilms. 
Method: The study was carried out at the Department of Microbiology, Army Medical College, 
National University of Sciences and Technology, Pakistan, from January 2010 to June 2010. A total of 
110 clinical isolates were subjected to biofilm detection methods. Isolates were identified by standard 
microbiological procedures. Biofilm detection was tested by TCP, TM and CRA. Antibiotic suscep-
tibility test of biofilm producing bacteria was performed by using the Kirby-Bauer disc diffusion 
technique according to CLSI guidelines. Results: The TCP method was considered to be superior to 
TM and CRA. From the total of 110 clinical isolates, TCP method detected 22.7% as high, 41% mod-
erate and 36.3% as weak or non-biofilm producers. We have observed higher antibiotic resistance 
in biofilm producing bacteria than non-biofilm producers. Conclusion: We can conclude from our 
study that the TCP method is a more quantitative and reliable method for the detection of biofilm 
forming microorganisms as compared to TM and CRA methods, and it can be recommended as a 
general screening method for detection of biofilm producing bacteria in laboratories. 
Keywords: biofilms; bacteria; anti-bacterial agents.
INTRODUCTION
Biofilms are defined as microbially derived ses-
sile communities characterized by the cells that 
are irreversibly attached to a substratum or to 
each other. They are embedded in a matrix of 
extracellular polymeric substances (EPS) they 
have produced, and exhibit an altered phe-
notype with respect to growth rate and gene 
transcription.1 Within a biofilm, bacteria com-
municate with each other by production of 
chemotactic particles or pheromones, a phe-
nomenon called quorum sensing.2 Availability 
of key nutrients, chemotaxis towards surface, 
motility of bacteria, surface adhesins and pres-
ence of surfactants are some factors which in-
fluence biofilm formation.2 Microorganisms 
growing in a biofilm are intrinsically more re-
sistant to antimicrobial agents than planktonic 
cells. High antimicrobial concentrations are 
required to inactivate organisms growing in 
a biofilm, as antibiotic resistance can increase 
1,000 fold.3 According to a publication by the 
National Institutes of Health, more than 80% of 
all infections involve biofilms.4 Biofilms are as-
sociated with many medical conditions includ-
ing indwelling medical devices, dental plaque, 
upper respiratory tract infections, peritonitis, 
and urogenital infections.5 Both Gram-positive 
and Gram-negative bacteria have the capability 
to form biofilms. Bacteria commonly involved 
include Enterococcus faecalis, Staphylococcus 
aureus, Staphylococcus epidermidis, Streptococ-
cus viridans, Escherichia coli, Klebsiella pneu-
moniae, Proteus mirabilis and Pseudomonas 
aeruginosa.6 There are various methods to 
detect biofilm production. These include the 
Tissue Culture Plate (TCP),7 Tube method 
(TM),8 Congo Red Agar method (CRA),9 bio-
luminescent assay,10 piezoelectric sensors,11 
and fluorescent microscopic examination.12 
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We screened 110 organisms by three different methods, 
which could be used in a routine clinical laboratory, for 
determining their ability to form biofilm.
OBJECTIVES
The study was conducted to detect biofilm forming microor-
ganisms isolated from clinical specimens by three different 
methods (TCP, TM, CRA) and to compare these methods 
for biofilm detection.
MATERIALS AND METHODS
Place and duration of the study
The study was conducted at the Department of Microbiol-
ogy, Army Medical College, National University of Sciences 
and Technology, Pakistan, from January 2010 to June 2010.
Selection of the isolates
A total of 110 clinical isolates were subjected to biofilm de-
tection methods. Organisms were selected on the following 
criteria: those isolated from the pus, intravenous and urinary 
catheter tips, urine, sputum and nasobronchial lavage speci-
mens, and those showing increased resistance to commonly 
available antibiotics by Kirby-Bauer disc diffusion method. 
Urinary catheter tips, intravenous catheter tips, nasobron-
chial lavage specimens and few of the pus specimens were 
related to medical devices (Table 1). All of the specimens 
were received from patients with nosocomial infections ad-
mitted to the hospital.
Isolates were identified by standard microbiological pro-
cedures (Gram staining, colonial morphology, catalase test, 
cytochrome oxidase reaction, motility, biochemical tests). 
Reference strain of positive biofilm producer Staphylococcus 
epidermidis ATCC 35984, Staphylococcus aureus ATCC 
35556, Pseudomonas aeruginosa ATCC 27853, Escherichia 
coli ATCC 35218 and Staphylococcus epidermidis ATCC 
12228 (non-slime producer) were used as control. Biofilm 
detection was done by the following methods:
Tissue culture plate method
This quantitative test described by Christensen et al.7 is con-
sidered the gold-standard method for biofilm detection.13 
Organisms isolated from fresh agar plates were inoculated in 
10 mL of trypticase soy broth with 1% glucose. Broths were 
incubated at 37oC for 24 h. The cultures were then diluted 
1:100 with fresh medium. Individual wells of sterile 96 well-
flat bottom polystyrene tissue culture treated plates (Sigma-
Aldrich, Costar, USA) were filled with 200 µL of the diluted 
cultures. The control organisms were also incubated, diluted 
and added to tissue culture plate. Negative control wells con-
tained inoculated sterile broth. The plates were incubated at 
37oC for 24 h. After incubation, contents of each well were 
removed by gentle tapping. The wells were washed with 
0.2 mL of phosphate buffer saline (pH 7.2) four times. This 
removed free floating bacteria. Biofilm formed by bacteria 
adherent to the wells were fixed by 2% sodium acetate and 
stained by crystal violet (0.1%). Excess stain was removed by 
using deionized water and plates were kept for drying. Opti-
cal density (OD) of stained adherent biofilm was obtained 
by using micro ELISA autoreader (model 680, Biorad, UK) 
at wavelength 570 nm. The experiment was performed in 
triplicate and repeated three times. The interpretation of 
biofilm production was done according to the criteria 
of Stepanovic et al.14 (Table 2).
Tube method
Described by Christensen et al.,8 this is a qualitative 
method for biofilm detection. A loopful of test organ-
isms was inoculated in 10 mL of trypticase soy broth with 
1% glucose in test tubes. The tubes were incubated at 
37oC for 24 h. After incubation, tubes were decanted and 
washed with phosphate buffer saline (pH 7.3) and dried. 
Tubes were then stained with crystal violet (0.1%). Ex-
cess stain was washed with deionized water. Tubes were 
dried in inverted position. The scoring for tube method 
was done according to the results of the control strains. 
Biofilm formation was considered positive when a visible 
film lined the wall and the bottom of the tube. The amount 
of biofilm formed was scored as 1-weak/none, 2-moder-
ate and 3-high/strong. The experiment was performed in 
triplicate and repeated three times.
Congo Red Agar method
Freeman et al.9 have described a simple qualitative method 
to detect biofilm production by using Congo Red Agar 
(CRA) medium. CRA medium was prepared with brain 
heart infusion broth (Oxoid, UK) 37 g/L, sucrose 50 g/L, 
agar No. 1 (Oxoid, UK) 10 g/L and Congo Red indicator 
(Oxoid, UK) 8 g/L. First Congo Red stain was prepared as 
a concentrated aqueous solution and autoclaved (121oC for 
15 minutes) separately from the other medium constitu-
ents. Then it was added to the autoclaved brain heart infu-
sion agar with sucrose at 55oC.5 CRA plates were inoculated 
with test organisms and incubated at 37oC for 24 h aerobi-
cally. Black colonies with a dry crystalline consistency 
indicated biofilm production.5 The experiment was per-
formed in triplicate and repeated three times.
Antibiotic susceptibility test of biofilm produc-
ing bacteria was done on Mueller Hinton agar (Oxoid, 
UK) using the following antibiotic discs: ampicillin, 
cotrimoxazole, ciprofloxacin, aztreonam, meropenem, 
cefoperazone-sulbactam, chloramphenicol, vancomy-
cin, erythromycin, amoxicillin-clavulanic acid, oxacil-
lin, linezolid, penicillin. All antibiotic discs were ob-
tained from Oxoid, UK. Escherichia coli ATCC 25922, 
Pseudomonas aeruginosa ATCC 27853 and Staphylococcus 
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Table 1. Correlation of biofilm production of isolates and sensitivity test with the patient clinical condition and 
type of medical device used
Organism Biofilm Pt. clinical Type of Sensitivity to 
 production condition/Type medical following 
  of infection device antibiotics
E. coli Strong Urine retention due  Foley’s urinary Amikacin, meropenem, 
  to stroke catheter cefoperazone-sulbactam
S. epidermidis Strong Care of a metastatic Urinary catheter Vancomycin,   
  terminal disease   linezolid, ciprofloxacin
E. coli Strong For relief of bladder Foley’s urinary catheter Aztreonam, meropenem 
  outlet obstruction due  
  to urethral stricture
E. faecalis Moderate Neurogenic bladder Foley’s urinary catheter Vancomycin, linezolid,  
    cotrimoxazole
E. coli Strong Benign prostatic Foley’s urinary catheter Ciprofloxacin,   
  hypertrophy  aztreonam, meropenem
E. coli Strong Post-operation to Foley’s urinary catheter Aztreonam, meropenem, 
   monitor output ciprofloxacin  
S. epidermidis Strong Urologic surgery Foley’s urinary catheter Vancomycin,   
    linezolid, ciprofloxacin
K. pneumoniae Strong Urine retention due Foley’s urinary catheter Cotrimoxazole,   
  to calculus disease   ciprofloxacin,   
    ceftriaxone, meropenem
E. coli Strong Urine retention due to  Foley’s urinary catheter Amikacin,   
  cerebrovascular disease  ceftriaxone, meropenem
K. pneumoniae Strong Hip fracture surgery Foley’s urinary catheter Ciprofloxacin,   
    ceftriaxone, meropenem
E. coli Strong Post-operation Foley’s urinary catheter Meropenem, amikacin,  
  to monitor output   aztreonam, ceftriaxone
S. epidermidis Strong Care for traumatic  Foley’s urinary catheter Vancomycin, linezolid,  
  spinal cord injury  cotrimoxazole,   
    ciprofloxacin
S. epidermidis Moderate Neurogenic bladder Foley’s urinary catheter Linezolid, ciprofloxacin,  
    cotrimoxazole
E. coli Strong Total abdominal Foley’s urinary catheter Ceftriaxone, meropenem 
  hysterectomy surgery   
S. epidermidis Moderate Bladder outlet Foley’s urinary catheter Vancomycin, linezolid, 
  obstruction due   cotrimoxazole,   
  to urethral stricture  ciprofloxacin  
E. coli Strong Urologic surgery Foley’s urinary catheter Meropenem, ceftriaxone 
    
E. coli Strong Benign prostatic Foley’s urinary catheter Ciprofloxacin, aztreonam,  
  hypertrophy  meropenem
K. pneumoniae Strong Palliative care in a  Foley’s urinary catheter Aztreonam, meropenem 
  incontinent impaired  
  patient  
S. epidermidis Strong Monitoring of central Central venous catheter Linezolid, ciprofloxacin 
  venous pressure    
  in an acutely ill patient
(Cont.)
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Table 1. Correlation of biofilm production of isolates and sensitivity test with the patient clinical condition and 
type of medical device used
Organism Biofilm Pt. clinical Type of Sensitivity to 
 production condition/Type medical following 
  of infection device antibiotics
S. epidermidis Moderate Total parenteral nutrition Central venous catheter Vancomycin, linezolid, 
    cotrimoxazole,   
    ciprofloxacin
K. pneumoniae Strong Long term IV antibiotics Intravenous catheter Aztreonam,   
    cefoperazone-sulbactam,  
    meropenem
S. epidermidis Strong To correct electrolyte Intravenous catheter Vancomycin, linezolid,  
  imbalance, fluid   Ciprofloxacin 
  replacement   
S. aureus Moderate Blood transfusion Intravenous catheter Rifampicin, ciprofloxacin  
    vancomycin
S. epidermidis Strong Total parenteral Central venous catheter Linezolid,   
  nutrition  cotrimoxazole
S. epidermidis Strong Monitoring of central  Central venous catheter Vancomycin,   
  venous pressure in  ciprofloxacin 
  a patient in ICU
K. pneumoniae Strong Pneumonia in a Endotracheal tube Meropenem, ceftriaxone,  
  patient on ventilator  aztreonam
P. aeruginosa Strong Ventilator associated Endotracheal tube Cefoperazone-sulbactam,  
  pneumonia  amikacin, meropenem
S. epidermidis Moderate Prosthetic joint infection Artificial joint Vancomycin, linezolid,  
    ciprofloxacin
S. epidermidis Strong Acute renal failure/ PD Catheter Vancomycin, linezolid, 
  peritoneal dialysis/   cotrimoxazole,   
  cellulites, peritonitis   ciprofloxacin
S. aureus Moderate Prosthetic joint infection Artificial joint Rifampicin, linezolid,  
    vancomcin, erythromycin
aureus ATCC 29213 were used as control strains. An-
tibiotic susceptibility test was performed by using the 
Kirby-Bauer disc diffusion technique according to CLSI 
guidelines.15
RESULTS
Among 110 isolates, TCP, the standard method, detected 
25 as strong and 45 as moderate biofilm producers. The 
majority of the organisms associated with biofilm produc-
tion were S. epidermidis (37.1%) followed by E. coli (27.1%), 
K. pneumoniae (15.7%), S. aureus (11.4%), E. faecalis 
(4.2%) and P. aeruginosa (4.2%). Biofilm producing bac-
teria were isolated from urine (30%) followed by urinary 
catheter tips (25.7%), pus (12.8%), sputum (11.4%), in-
travenous catheter tips (10%) and nasobronchial lavage 
specimens (10%). Strong biofilm production was caused by 
E. coli and S. epidermidis on Foley’s urinary catheter, 
mainly in immunocompromised patients, sensitive pre-
dominantly to meropenem, aztreonam, vanomycin and 
linezolid. S. epidermidis was responsible for strong biofilm 
Evaluation of different detection methods of biofilm formation in the clinical isolates
Table 2. Interpretation of biofilm production
Average OD value Biofilm production
≤ ODc / ODc < ~ ≤ 2x ODc  Non/weak
2x ODc < ~ ≤ 4x ODc  Moderate
> 4x ODc  Strong
Optical density cut-off value (ODc) = average OD of negative 
control + 3x standard deviation (SD) of negative control.
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Table 3. Screening of the isolates for biofilm formation by Tissue Culture Plate, Tube Method and Congo Red 
Agar methods
 Biofilm formation TCM n (%) TM n (%) CRA n (%)
No. of isolates (110)
 High 25 (22.7) 21 (19) 4 (3.6)
 Moderate 45 (41) 33 (30) 7 (6.3)
 Weak/none 40 (36.3) 56 (51) 99 (90)
Table 4. Resistance pattern (%) of biofilm producing Gram-positive bacteria
Antimicrobial agent Biofilm producing Non-biofilm producing  
 Gram-positive organisms  Gram-positive organisms
 % %
Penicillin 100 100
Rifampicin 70 30
Ciprofloxacin 40 10
Erythromycin 40 20
Cotrimoxazole 30 25
Linezolid 0 0
Vancomycin 0 0
Table 5. Resistance pattern (%) of biofilm producing Gram-negative bacteria
Antimicrobial agent Biofilm producing  Non-biofilm producing  
 Gram-negative organisms Gram-negative organisms 
 % %
Ampicillin 100 100
Ciprofloxacin 95 50
Cotrimoxazole 90 83
Aztreonam 90 50
Amikacin 64 37
Ceftriaxone 58 33
Cefoperazone-sulbactam 36 0
Meropenem 0 0
production in patients with intravenous catheters, sensi-
tive mostly to linezolid and vancomycin (Table 1).
By TM, the number of strong biofilm producers were 
21, moderate were 33 and weak or non-biofilm producers 
were 56. Very different results were observed by the CRA 
method, with which only four isolates showed black colo-
nies with crystalline appearance (Table 3).
We have observed higher antibiotic resistance in bio-
film producing bacteria than non-biofilm producers. By 
the standard method (TCP), biofilm producing bacteria 
include the strong (25) and moderate biofilm producers 
(45), and non-biofilm producing bacteria include non-
biofilm producers (40) (Tables 4 and 5).
Hassan, Usman, Kaleem et al.
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Statistical analysis of tissue culture plate, tube and 
Congo Red Agar methods
The TCP method was considered the gold-standard for this 
study and compared with data from TM and CRA meth-
ods. Parameters like sensitivity, specificity, negative predic-
tive value, positive predictive value and accuracy were cal-
culated. True positives were biofilm producers by TCP, TM 
and CRA method. False positive were biofilm producers by 
TM and CRA method and not by TCP method. False nega-
tive were the isolates which were non-biofilm producers by 
TM and CRA but were producing biofilm by TCP method. 
True negatives are those which were non biofilm producers 
by all the three methods. Sensitivity and specificity of TM 
was 73% and 92.5%, respectively. For CRA method, sensi-
tivity and specificity remained low and were 11% and 92%, 
respectively (Table 6).
DISCUSSION
Biofilm producing bacteria are responsible for many recal-
citrant infections and are notoriously difficult to eradicate. 
They exhibit resistance to antibiotics by various methods like 
restricted penetration of antibiotic into biofilms, decreased 
growth rate and expression of resistance genes.16 There are 
various methods for biofilm detection.7-12 In this study we 
evaluated 110 isolates by three screening methods for their 
ability to form biofilms.
In our study, we have found that the majority of biofilm 
producing bacteria was from urinary catheter tips (26.3%). 
Similarly, Donlan6 reported in his study the association of 
biofilm producing bacteria with urinary catheters. 
In the TCP method, the number of isolates showing bi-
ofilm formation was 70 (64.7%), and non or weak biofilm 
producers were 40 (36.3%). Regional data from India also 
showed that out of 152 isolates tested, the number of bio-
film producers identified by TCP method was 53.9 %, and 
non-biofilm producers were 46%.13 We have performed the 
TCP method by addition of 1% glucose in trypticase soy 
broth. Addition of sugar helps in biofilm formation.16,17 
This was also reported by studies conducted by Mathur et 
al.13 and Bose et al.18
Tube method detected 49% isolates as biofilm producers 
and 51% as non-biofilm producers. By this method, three iso-
lates were found to be false positive and 19 were false negative. 
TM is 73% sensitive, 92.5% specific and 80% accurate for 
biofilm detection. This method correlated well with TCP 
for identifying strong biofilm producers, but it was hard to 
differentiate between moderate, weak and non-biofilm pro-
ducers due to the changeability in the results detected by 
different observers. In accordance with the preceding stud-
ies, TM cannot be suggested as general screening test to 
identify biofilm producing isolates.8,13
In another study, Ruzicka et al.19 noted that out of 147 iso-
lates of S. epidermidis, TM detected biofilm formation in 79 
(53.7%) and CRA detected in 64 (43.5%) isolates. They showed 
that TM is better for biofilm detection than CRA.19 Baqai 
et al.20 tested TM to detect biofilm formation among uropatho-
gens. According to their results, 75% of the isolates exhibited 
biofilm formation.20 With the CRA method, 11 were found to 
be biofilm producing bacteria and 99 as non-biofilm produc-
ers. The CRA method showed very little correlation with the 
other methods and parameters of sensitivity (11%), specificity 
(92%) and accuracy (41%) were very low. By this method, three 
isolates were found to be false positive and 62 were false nega-
tive. Knobloch et al.21 did not recommend the CRA method for 
biofilm detection in their study. Out of 128 isolates of S. aureus, 
CRA detected only 3.8% as biofilm producers as compared to 
TCP which detected 57.1% as biofilm producing bacteria.21
CONCLUSION
We can conclude from our study that TCP is a quantitative 
and reliable method to detect biofilm forming microorgan-
isms. When compared to TM and CRA methods, and TCP 
can be recommended as a general screening method for de-
tection of biofilm producing bacteria in laboratories.
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